As Yet Another Wave of Covid Looms, New Yorkers Ask: Should I Worry?
Quotes Executive Director Denis Nash | The New York Times | April 7, 2022
Quotes Executive Director Denis Nash | The New York Times | April 7, 2022
A study by CUNY SPH researchers, in close partnership with colleagues from Weill Cornell Medicine and NYU School of Medicine, suggests that treating people who inject drugs for hepatitis C infection using […]
Quotes Executive Director Denis Nash | The New York Times | March 23, 2022
Radio show with Executive Director Denis Nash | WNYC | March 11, 2022
We aimed to ascertain the extent to which active infections are underestimated by case reporting in standard surveillance (i.e., results reported to the state public health agency after testing at […]
Quotes Executive Director Denis Nash | Gothamist | February 28, 2022
Quotes Executive Director Denis Nash | Market Watch | February 28, 2022
Since pre-exposure prophylaxis (PrEP) was approved by the FDA in 2012, fewer people than expected have initiated use of the drug. Researchers also have reported high rates of PrEP discontinuation […]
Quotes Executive Director Denis Nash | Newsday | February 20, 2022
Quotes Executive Director Denis Nash | Chalkbeat New York | February 16, 2022